N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.
Jianbo TianYing ZhuMeilin RaoYimin CaiZequn LuDanyi ZouXiating PengPingting YingMing ZhangSiyuan NiuYue LiRong ZhongJiang ChangXiaoping MiaoPublished in: Gut (2020)
These findings demonstrate aberrant m6A homoeostasis as an oncogenic mechanism in PDAC and highlight the potential of PIK3CB as a therapeutic target for this disease.